Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, ...

Advanced Biomed Inc. (the "Company") (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, today announced the closing of ...

Tainan, Taiwan, March 06, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, diagnosis ...

With more than three weeks left in the first quarter, the value of med-tech IPOs for 2025 already exceeds the funds raised ...

Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD -- Flexible Dosing and Extended Duration would be Important ...

Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX), a leading provider of mission-critical ...

The global meningitis treatment industry, valued at USD 150.9 million in 2023, is projected to grow at a CAGR of 4.1% from ...

Soligenix (SNGX) , a late-stage biopharmaceutical company focused on rare diseases, announced that its lead investigators will present findings from ...

Q4 2024 Earnings Call Transcript March 4, 2025 InfuSystem Holdings, Inc. misses on earnings expectations. Reported EPS is ...

Calidi Biotherapeutics (NYSE American: CLDI) is leveraging innovative platforms in a commitment to transform cancer treatment using advanced biotech ...